PARP inhibitors can play a significant role in the first-line setting for patients with advanced ovarian cancer.
CU Anschutz
Anschutz Cancer Pavilion
1665 North Aurora Court
2004
Aurora, CO 80045
Home News Clinical Commentary: Managing Adverse Events From PARP Inhibitors in Advanced Ovarian Cancer back to News
minute read
PARP inhibitors can play a significant role in the first-line setting for patients with advanced ovarian cancer.
Topics: Press Coverage
1665 North Aurora Court
2004
Aurora, CO 80045
720-848-0300
© 2024 The Regents of the University of Colorado, a body corporate. All rights reserved.
Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.